Generate Biomedicines, Inc.
GENBBiotechnology
$14.46−8.31%As of Oct 30vs prior close
- Market cap
- $1.9B
- P/E (TTM)
- –
- From 52W high
- −29.05%
- EPS (LTM)
- -$2.44
- Revenue (LTM)
- $26.5M
- Net margin
- -897.71%
Nomior Score
31
Steady ProfileBottom 16% of the scored universe
Growth34
Quality39
Value37
Momentum—
Resilience38
Growth
+55.89%revenue a year over 1 fiscal year
YE24 $20.5MLTM $26.5M
Connections
Revenue to profitYE25
The net loss was 637% of revenue, narrower by 212 pts on a year.
Who owns it
2funds